{
  "id": "168ab7c71f579825",
  "title": "Dr Jhaveri on the FDA Approval of Imlunestrant for ESR1+ Breast Cancer",
  "description": "20251207T163000Z",
  "content": "",
  "source": "onclive.com",
  "source_url": "https://www.onclive.com/view/dr-jhaveri-on-the-fda-approval-of-imlunestrant-for-esr1-breast-cancer",
  "published_at": "20251207T163000Z",
  "fetched_at": "2025-12-08T00:22:54.837391+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.onclive.com/view/dr-jhaveri-on-the-fda-approval-of-imlunestrant-for-esr1-breast-cancer",
    "url_mobile": "",
    "title": "Dr Jhaveri on the FDA Approval of Imlunestrant for ESR1+ Breast Cancer",
    "seendate": "20251207T163000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/onclive/c5db606c7ed6a9c8e1ae435d1f622db37ec87fe6-1280x720.jpg",
    "domain": "onclive.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}